HomeNIRV • CNSX
add
Nirvana Life Sciences Inc
Previous close
$0.060
Year range
$0.030 - $0.80
Market cap
289.40K CAD
Avg Volume
595.00
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Jan 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 62.53K | -61.47% |
Net income | -78.73K | 66.38% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -57.95K | 63.37% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Jan 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 638.00 | -79.66% |
Total assets | 20.44K | -90.35% |
Total liabilities | 1.36M | 31.74% |
Total equity | -1.33M | — |
Shares outstanding | 4.82M | — |
Price to book | -0.21 | — |
Return on assets | -144.63% | — |
Return on capital | 12.97% | — |
Cash Flow
Net change in cash
| (CAD) | Jan 2025info | Y/Y change |
|---|---|---|
Net income | -78.73K | 66.38% |
Cash from operations | -14.11K | -66.68% |
Cash from investing | — | — |
Cash from financing | -128.73K | -6,667.91% |
Net change in cash | -6.99K | -7.52% |
Free cash flow | -2.07K | -103.45% |
About
Founded
2011
Headquarters
Website
Employees
2
